Almac Group

Almac Group is a global pharmaceutical development and manufacturing organization providing a comprehensive range of services including Active Pharmaceutical Ingredient (API) manufacturing, analytical testing, clinical supply, commercial manufacturing, and pharmaceutical logistics. Founded in 1968 and headquartered in Craigavon, Northern Ireland, United Kingdom, Almac has established itself as a trusted partner for pharmaceutical and biotechnology companies worldwide.

The company’s API Services division specializes in custom synthesis, process research and development, scale-up, highly potent active pharmaceutical ingredients (HPAPIs), peptide chemistry, and commercial manufacturing. Almac supports projects from early discovery through clinical development and commercial production, helping clients accelerate drug development while maintaining exceptional quality and regulatory compliance.

Almac operates modern research and manufacturing facilities across Europe, North America, and Asia-Pacific. Its integrated capabilities enable pharmaceutical companies to streamline development while benefiting from advanced scientific expertise, secure supply chains, and flexible manufacturing solutions. The company places strong emphasis on innovation, sustainability, digital transformation, and long-term customer partnerships. Through continuous investment in research, technology, and manufacturing infrastructure, Almac remains one of the pharmaceutical industry’s most respected providers of API development and manufacturing services.